Dengue virus type 4 arrives in the state of Rio de Janeiro: a challenge for epidemiological surveillance and control Dengue virus type 4 (DENV-4) re-emerged in the state of Roraima (RR), a remote state in the extreme Northwest of Brazil, in July 2010 at the height of the rainy season. This serotype had not been detected in the country for almost 30 years, when DENV-4 and DENV-1 caused a limited outbreak in RR's capital city Boa Vista in [1981][1982] with 11,000 reported cases. The reinvasion of DENV-4 in July 2010 was not followed by an epidemic in RR; less than 20 cases of DENV-4 were confirmed in this state throughout the second half of 2010. The first cases, which were considered to have been the result of the virus spreading from RR, were not registered until January 2011. First, the virus reached two states of the Northern Region, Amazonas and Pará, in January. In March, the virus was subsequently detected in the Northeast Region, first in the state of Piauí and later in the states of Pernambuco, Bahia and Ceará, and in the Southeast Region, in the states of Rio de Janeiro (RJ) and São Paulo. The arrival of this serotype in RJ eight months after its resurgence in RR, almost 5,000 km away, has important and particular epidemiological significance. Furthermore, its early detection during the course of a DENV-1 epidemic reveals the efficiency of an epidemiological surveillance.
Since 1986, Niterói has established a surveillance system for dengue fever, including collecting blood for virus detection (culture inoculation and PCR) from fever cases until the fifth day after the onset of symptoms in Health Centres from the Sentinela network. The identification of DENV-4 confirmed the co-circulation of three serotypes, DENV-1, DENV-2 and DENV-4; DENV-3 has not been isolated since 2008.
Niterói's basic healthcare network consists of 54 units. Each unit has at least one surveillance professional, which allows surveillance and assistance to work well together, making information flow faster. The experience gained from past epidemics is presented in meetings, in capacity-building courses for professionals and in informational materials. The epidemiological surveillance office publishes a bulletin (Informe dengue) that is released every week during the warning phase and when the epidemic has set. All Health Units offer blood collection services and other materials for laboratory exams, and the Municipal Health Foundation has its own network of laboratories made up of three laboratories that render services for the basic healthcare network and four laboratories for the hospital network.
The dengue fever virological surveillance protocol currently in use recommends collecting blood samples for serology tests in fever cases after the seventh day of the disease (children, expecting mothers, elderly, people with comorbidities, severe cases), in addition to investigating deaths. Patients who receive medical care until the fifth day of the disease (feverish period) are eligible to have samples collected for viral isolation.
The municipality of Niterói has stood out in the epidemiology of dengue fever in Brazil, with the early description of dengue fever's clinical picture in 1923 by Antonio Pedro. Furthermore, it was in this municipality that DENV-2 was first isolated in April 1990. Two months later, Niterói was where the first case of dengue haemorrhagic fever in Brazil was registered based on criteria from the World Health Organization. Curiously, the first isolation of DENV-2 (1990) and DENV-4 (2011) in RJ occurred during an outbreak of DENV-1 (Supplementary data).
Historically, the arrival of a new type of dengue fever in RJ has shown to be explosive during the rainy seasons after the detection of the first cases, following a rapid dissemination into the large metropolitan area and to other states, as described by the virological research and surveillance conducted by the late Dr Hermann Schatzmayr's team during the past 25 years. The arrival of DENV-4 in RJ represents once more another great challenge for epidemiological surveillance, control and healthcare in Brazil.
The situation of hyperendemicity in the state (several co-circulating serotypes) of a virus of renowned pathogenicity in RJ, as well as the possibility of sequential infections, has led to the appearance of severe forms of the disease in the state, even in children. Therefore, providing clinical management, organizing healthcare and maintaining an efficient surveillance system are of the utmost importance in reducing dengue mortality.
Rita MR Nogueira
Laboratório de Flavivírus, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brasil
Ana LF Eppinghaus
Fundação Municipal de Saúde de Niterói, Niterói, RJ, Brasil
